These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 12577238)

  • 1. Down-regulation of intestinal-type alkaline phosphatase in the tumor vasculature and stroma provides a strong basis for explaining amifostine selectivity.
    Giatromanolaki A; Sivridis E; Maltezos E; Koukourakis MI
    Semin Oncol; 2002 Dec; 29(6 Suppl 19):14-21. PubMed ID: 12577238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amifostine induces anaerobic metabolism and hypoxia-inducible factor 1 alpha.
    Koukourakis MI; Giatromanolaki A; Chong W; Simopoulos C; Polychronidis A; Sivridis E; Harris AL
    Cancer Chemother Pharmacol; 2004 Jan; 53(1):8-14. PubMed ID: 14574457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amifostine protects blood vessels from the effects of ionizing radiation.
    Giannopoulou E; Katsoris P; Parthymou A; Kardamakis D; Papadimitriou E
    Anticancer Res; 2002; 22(5):2821-6. PubMed ID: 12530003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioprotective effects of amifostine.
    Wasserman T
    Semin Oncol; 1999 Apr; 26(2 Suppl 7):89-94. PubMed ID: 10348266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microvessel density and endothelial cell proliferation after amifostine (Ethyol) administration in vivo.
    Plasswilm L; Hanjalic A; Hoeper J; Cordes N; Tannapfel A
    Anticancer Res; 1999; 19(5B):4241-5. PubMed ID: 10628381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Radioprotective effects on head and neck tumors of amifostine--a broad-spectrum cytoprotection].
    Huang R; Yu H; Kuang A
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2002 Dec; 19(4):708-11. PubMed ID: 12561384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical implications of fibroblast activation protein in patients with colon cancer.
    Henry LR; Lee HO; Lee JS; Klein-Szanto A; Watts P; Ross EA; Chen WT; Cheng JD
    Clin Cancer Res; 2007 Mar; 13(6):1736-41. PubMed ID: 17363526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical detection of P-glycoprotein on frozen and paraffin-embedded tissue sections of normal and malignant tissues.
    Bittl A; Nap M; Jäger W; Cornillie F; Lang N
    Anticancer Res; 1995; 15(3):1007-14. PubMed ID: 7645919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epithelial-mesenchymal cell interactions and participation of the neuroendocrine markers in tumor development. Immunohistochemical study.
    Zółtowska A; Stepiński J; Kuczkowski J; Kamiński M; Cynowska B; Kruszewski W
    Arch Immunol Ther Exp (Warsz); 1998; 46(4):247-51. PubMed ID: 9779291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malformations of angiogenesis in the low differentiated human carcinomas. immunohistochemical study.
    Zółtowska A; St piński J; Lewko B; Zamorska B; Roszkiewicz A; Serkies K; Kruszewski WJ
    Arch Immunol Ther Exp (Warsz); 2001; 49(1):59-61. PubMed ID: 11266092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The A3 adenosine receptor is highly expressed in tumor versus normal cells: potential target for tumor growth inhibition.
    Madi L; Ochaion A; Rath-Wolfson L; Bar-Yehuda S; Erlanger A; Ohana G; Harish A; Merimski O; Barer F; Fishman P
    Clin Cancer Res; 2004 Jul; 10(13):4472-9. PubMed ID: 15240539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of Calponin h1 expression in human colon cancer blood vessels.
    Yanagisawa Y; Takeoka M; Ehara T; Itano N; Miyagawa S; Taniguchi S
    Eur J Surg Oncol; 2008 May; 34(5):531-7. PubMed ID: 17707120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of biliary glycoprotein (CD66a) in normal and malignant breast epithelial cells.
    Huang J; Simpson JF; Glackin C; Riethorf L; Wagener C; Shively JE
    Anticancer Res; 1998; 18(5A):3203-12. PubMed ID: 9858884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The preclinical basis for broad-spectrum selective cytoprotection of normal tissues from cytotoxic therapies by amifostine.
    Capizzi RL
    Semin Oncol; 1999 Apr; 26(2 Suppl 7):3-21. PubMed ID: 10348255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
    Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A
    BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of transmembrane protein tyrosine phosphatase gamma (PTPgamma) in normal and neoplastic human tissues.
    Vezzalini M; Mombello A; Menestrina F; Mafficini A; Della Peruta M; van Niekerk C; Barbareschi M; Scarpa A; Sorio C
    Histopathology; 2007 Apr; 50(5):615-28. PubMed ID: 17394498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneous expression of the aquaporin 1 (AQP1) water channel in tumors of the prostate, breast, ovary, colon and lung: a study using high density multiple human tumor tissue microarrays.
    Mobasheri A; Airley R; Hewitt SM; Marples D
    Int J Oncol; 2005 May; 26(5):1149-58. PubMed ID: 15809704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of platelet-derived endothelial cell growth factor in inflammatory bowel disease.
    Saito S; Tsuno NH; Sunami E; Hori N; Kitayama J; Kazama S; Okaji Y; Kawai K; Kanazawa T; Watanabe T; Shibata Y; Nagawa H
    J Gastroenterol; 2003; 38(3):229-37. PubMed ID: 12673445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of syndecan-1 in paired samples of normal and malignant breast tissue from postmenopausal women.
    Lofgren L; Sahlin L; Jiang S; Von Schoultz B; Fernstad R; Skoog L; Von Schoultz E
    Anticancer Res; 2007; 27(5A):3045-50. PubMed ID: 17970043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemopreventive doses of amifostine confer no cytoprotection to tumor nodules growing in the lungs of mice treated with cyclophosphamide.
    Grdina DJ; Hunter N; Kataoka Y; Murley JS; Milas L
    Semin Oncol; 1999 Apr; 26(2 Suppl 7):22-7. PubMed ID: 10348256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.